Low frequency mutation of the Ephrin receptor A3 gene in hepatocellular carcinoma

被引:19
作者
Bae, H. J. [1 ]
Song, J. H. [1 ]
Noh, J. H. [1 ]
Kim, J. K. [1 ]
Jung, K. H. [1 ]
Eun, J. W. [1 ]
Xie, H. J. [1 ]
Ryu, J. C. [2 ]
Ahn, Y. M. [3 ]
Kim, S. Y. [1 ]
Lee, S. H. [1 ]
Yoo, N. J. [1 ]
Lee, J. Y. [1 ]
Park, W. S. [1 ]
Nam, S. W. [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Pathol, Microdissect Genom Res Ctr, Seoul 137701, South Korea
[2] Korea Inst Sci & Technol, Cellular & Mol Toxicol Lab, Seoul 130650, South Korea
[3] Kyung Hee Univ, Dept Kidney Syst, Coll Oriental Med, Seoul, South Korea
关键词
Eph receptor; EphA3; hepatocellular carcinoma; mutation; SOMATIC MUTATIONS; CANCER; CELLS; EXPRESSION; GENOMICS; MELANOMA; SCREEN; FAMILY;
D O I
10.4149/neo_2009_04_331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EphA3 is a component of the Eph/ephrin tyrosine kinase system, which participates in vasculature development. This receptor/ligand system is associated with various signaling pathways related to cell growth and viability, cytoskeletal organization, cell migration, and anti-apoptosis. Accumulated evidence suggests that aberrant regulation of EphA3 and its genetic alterations are implicated in the development and progression of various cancers. However, despite a high incidence of EphA3 over-expression, no such investigation has been performed in hepatocellular carcinoma. Thus, we investigated genetic alterations of the EphA3 gene in 73 cases of hepatocellular carcinoma by single-strand conformational polymorphism and sequencing. One novel D219V missense mutation was found in the extracellular domain of EphA3, and two genetic alterations in the intracellular sterile-a-motif (SAM) domain of EphA3 appeared to be polymorphisms. Although the functional assessments of this mutant are incomplete, it is believed that this novel EphA3 mutation may contribute to the development of hepatocellular carcinoma.
引用
收藏
页码:331 / 334
页数:4
相关论文
共 23 条
[11]   Comparative and integrative functional genomics of HCC [J].
Lee, J-S ;
Thorgeirsson, S. S. .
ONCOGENE, 2006, 25 (27) :3801-3809
[12]   Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling [J].
Nam, SW ;
Park, JY ;
Ramasamy, A ;
Shevade, S ;
Islam, A ;
Long, PM ;
Park, CK ;
Park, SE ;
Kim, SY ;
Lee, SH ;
Park, WS ;
Yoo, NJ ;
Liu, ET ;
Miller, LD ;
Lee, JY .
HEPATOLOGY, 2005, 42 (04) :809-818
[13]   Clinicopathologic significance of genetic alterations in hepatocellular carcinoma [J].
Pang, A ;
Ng, IO ;
Fan, ST ;
Kwong, YL .
CANCER GENETICS AND CYTOGENETICS, 2003, 146 (01) :8-15
[14]   GENETIC CHANGES IN OVARIAN-CANCER [J].
PEJOVIC, T .
ANNALS OF MEDICINE, 1995, 27 (01) :73-78
[15]   AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 [J].
Satoh, S ;
Daigo, Y ;
Furukawa, Y ;
Kato, T ;
Miwa, N ;
Nishiwaki, T ;
Kawasoe, T ;
Ishiguro, H ;
Fujita, M ;
Tokino, T ;
Sasaki, Y ;
Imaoka, S ;
Murata, M ;
Shimano, T ;
Yamaoka, Y ;
Nakamura, Y .
NATURE GENETICS, 2000, 24 (03) :245-250
[16]   Ephrin-a1 induces, c-Cbl phosphorylation and EphA receptor down-regulation in T cells [J].
Sharfe, N ;
Freywald, A ;
Toro, A ;
Roifman, CM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (12) :6024-6032
[17]   Dissecting the EphA3/ephrin-A5 interactions using a novel functional mutagenesis screen [J].
Smith, FM ;
Vearing, C ;
Lackmann, M ;
Treutlein, H ;
Himanen, J ;
Chen, K ;
Saul, A ;
Nikolov, D ;
Boyd, AW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :9522-9531
[18]   EphA3 is induced by CD28 and 1GF-1 and regulates cell adhesion [J].
Smith, LM ;
Walsh, PT ;
Rüdiger, T ;
Cotter, TG ;
Mc Carthy, TV ;
Marx, A ;
O'Connor, R .
EXPERIMENTAL CELL RESEARCH, 2004, 292 (02) :295-303
[19]   Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma [J].
Song, Jaehwi ;
Kim, Chang Jae ;
Cho, Yong Gu ;
Kim, Su Young ;
Nam, Suk Woo ;
Lee, Sug Hyung ;
Yoo, Nam Jin ;
Lee, Jung Young ;
Park, Won Sang .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (08) :1286-1289
[20]   A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer [J].
Stephens, P ;
Edkins, S ;
Davies, H ;
Greenman, C ;
Cox, C ;
Hunter, C ;
Bignell, G ;
Teague, J ;
Smith, R ;
Stevens, C ;
O'Meara, S ;
Parker, A ;
Tarpey, P ;
Avis, T ;
Barthorpe, A ;
Brackenbury, L ;
Buck, G ;
Butler, A ;
Clements, J ;
Cole, J ;
Dicks, E ;
Edwards, K ;
Forbes, S ;
Gorton, M ;
Gray, K ;
Halliday, K ;
Harrison, R ;
Hills, K ;
Hinton, J ;
Jones, D ;
Kosmidou, V ;
Laman, R ;
Lugg, R ;
Menzies, A ;
Perry, J ;
Petty, R ;
Raine, K ;
Shepherd, R ;
Small, A ;
Solomon, H ;
Stephens, Y ;
Tofts, C ;
Varian, J ;
Webb, A ;
West, S ;
Widaa, S ;
Yates, A ;
Brasseur, F ;
Cooper, CS ;
Flanagan, AM .
NATURE GENETICS, 2005, 37 (06) :590-592